‘Watch-and-wait’ approach for low-risk prostate cancer not without dangers
March 7, 2019 | By Malcolm Bedell
Men diagnosed with “low-risk” prostate cancer are increasingly refusing more aggressive treatment in favor of a watch-and-wait approach. However, determining which patients truly fall into the “low-risk” category can prove more complicated than some tests would make it seem.
Patient Care | Research